Lianzhen Cui Selected Research

fucose-binding lectin

3/2017	Marine Lectins DlFBL and HddSBL Fused with Soluble Coxsackie-Adenovirus Receptor Facilitate Adenovirus Infection in Cancer Cells BUT Have Different Effects on Cell Survival.
3/2014	Exogenous expression of marine lectins DlFBL and SpRBL induces cancer cell apoptosis possibly through PRMT5-E2F-1 pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lianzhen Cui Research Topics

Disease

5	Neoplasms (Cancer) 03/2017 - 03/2014
2	Adenoviridae Infections (Adenovirus Infections) 03/2017 - 12/2015
2	Cicatrix (Scar) 03/2017 - 12/2015
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018
1	Infections 03/2017
1	Leukemia 12/2015
1	Melanoma (Melanoma, Malignant) 12/2015

Drug/Important Bio-Agent (IBA)

4	LectinsIBA 03/2017 - 03/2014
2	Chimeric Antigen ReceptorsIBA 01/2020 - 01/2018
2	Coxsackie and Adenovirus Receptor-Like Membrane ProteinIBA 03/2017 - 12/2015
2	Proteins (Proteins, Gene)FDA Link 03/2017 - 12/2015
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 03/2017 - 06/2014
2	fucose-binding lectinIBA 03/2017 - 03/2014
1	GlypicansIBA 01/2020
1	MesothelinIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 03/2017
1	AgglutininsIBA 03/2017
1	E2F1 Transcription FactorIBA 03/2017
1	Protein-Arginine N-Methyltransferases (Methyltransferase, Protein Arginine)IBA 04/2016
1	LigandsIBA 12/2015
1	InterleukinsIBA 12/2015
1	RhamnoseIBA 03/2014

Therapy/Procedure

1	Therapeutics 01/2018